1 |
王鲁平. 良性肝细胞病变的病理诊断及鉴别诊断2019年第五版WHO消化系统肿瘤关于良性肝细胞病变的更新及进展[J].诊断病理学杂志, 2020, 27(10): 730-738.
|
2 |
国际肝胆胰协会中国分会肝血管瘤专业委员会. 肝血管瘤诊断和治疗多学科专家共识(2019版) [J]. 中华消化外科杂志,2019, 18(8): 705-710.
|
3 |
刘荣, 赵之明. 正确认识“达芬奇”手术机器人在肝胆胰外科中的作用[J/OL].中华腔镜外科杂志(电子版), 2012, 5(2): 83-85.
|
4 |
van Rosmalen BV, de Graeff JJ, van der Poel MJ, et al. Impact of open and minimally invasive resection of symptomatic solid benign liver tumours on symptoms and quality of life: a systematic review[J]. HPB (Oxford), 2019, 21(9):1119-1130.
|
5 |
Lu SL, Yuan GD, Lei B, et al. Application of da Vinci surgery in hepatectomy[J]. Intelligent Surgery, 2022, 5: 6-11.
|
6 |
金亮, 蔡飞, 李琪, 等. 肝血管瘤患者瘤体剥除与介入栓塞术后生存质量对比评价[J]. 中国普通外科杂志, 2016, 25(1): 103-108.
|
7 |
张小昭, 王彦超, 连文波, 等. 外科手术与肝动脉介入栓塞治疗肝血管瘤临床分析[J]. 中华实用诊断与治疗杂志, 2015, 29(9): 875-876.
|
8 |
贾江坤, 余淼, 贾萌, 等. 腹腔镜辅助下血管瘤剥除术与解剖性肝切除术治疗巨大肝血管瘤疗效比较[J]. 实用肝脏病杂志,2024, 27(2): 287-290.
|
9 |
周宁新, 刘全达, 陈军周, 等. 机器人肝切除术:附17例报告[J]. 外科理论与实践, 2011, 16(6): 526-530.
|
10 |
车金辉, 嵇武, 丁凯, 等. 达芬奇手术机器人切除肝巨大血管瘤1例[J]. 东南国防医药, 2012, 14(2): 107-111.
|
11 |
Zhang W, Liu J, Zhang Z, et al. Perioperative outcomes of robotassistedversuslaparoscopicliverresectionforcavernous hemangioma: a propensity score matching study[J]. Surg Endosc,2023, 37(6):4505-4516.
|
12 |
Choi SH, Han DH, Lee JH, et al. Safety and feasibility of robotic major hepatectomy for novice surgeons in robotic liver surgery: a prospective multicenter pilot study[J]. Surg Oncol, 2020, 35:39-46.
|
13 |
李成刚, 赵之明, 胡明根, 等. 吲哚菁绿在机器人肝脏 FNH 切除术中的应用[J/OL].中华腔镜外科杂志(电子版), 2021, 14(1): 15-18.
|
14 |
Li J, Chen P. Current status and prospects of minimally invasive hepatobiliary surgery [J]. Intelligent Surgery, 2024, 7: 47-52.
|
15 |
Hu SY. The prospects of localization of surgical robots [J].Intelligent Surgery, 2023, 6: 73-74.
|